Changes to the Injeq Plc. Board

The Annual General Meeting held on May 31 2022 made the regular decisions as defined in the by-laws.

The new Board of Directors was elected in the Annual General Meeting and the five members are:

Jari Hyttinen
Tommi Majaus
Tomi Numminen
Tommi Rasila
Pekka Tammela

The new Board had the first meeting On June 8, 2022. Tomi Numminen was elected as the chairman of the Board of Directors and Tommi Rasila was elected as the vice-chair.

More information about the Board members is available on the Finnish – site: https://injeq.com/fi/sijoittajille/hallitus/

Injeq is one of the Europe’s Top 5 Medical Device Companies to Watch in 2023

Healthcare advancements that were mere ideas decades ago are coming to fruition, proving to be much more valuable to saving […]
Read more »

The 3rd part of Sievänen’s trilogy about traumatic lumbar punctures is out now: Incidence of traumatic lumbar punctures in adults: the impact of a patient’s first procedure

We are happy to announce that the last part of Sievänen’s traumatic lumbar punctures’ trilogy is now published. Two factors […]
Read more »

Päivi Lehtonen starting as Injeq’s new Sales Director in April

The current CEO of Teivo, Päivi Lehtonen, will start as Injeq’s new Sales Director in the beginning of April. Päivi […]
Read more »

We are excited to join the biggest German neurology event Neurowoche 2022

We are excited to join the biggest annual German neurology event Neurowoche 2022 with our distributor Ecumed. The congress takes […]
Read more »

Injeq participating Italian Neonatology congress SIN

Injeq is happy to join our Italian distributor Euromed at SIN – XXVIII Italian Neonatology Congress in beautiful Firenze. Come […]
Read more »

Injeq participating SIOP 2022 in Barcelona 28th September -1st October

Injeq is very excited to attend the SIOP Congress to present our amazing IQ-Tip system to doctors, patients and their […]
Read more »